Association between polymorphisms of ACE, B2AR, ANP and ENOS and cardiovascular diseases: A community-based study in the Matsu area

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 1, 2007, Pages 20-25

  Hu, Chaur Jong ^a   Wang, Chun Hsiung ^b,c   Lee, Jui Heng ^b   Hsieh, Chih Min ^b   Cheng, Chia Chi ^d   Chang, Shu Chen ^e   Chang, Chee Jen ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL UNITED UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

2 adrenal receptor (B2AR); Angiotensin converting enzyme (ACE); Atrial natriuretic peptide (ANP); Cardiovascular diseases; Community based; Endothelial nitric oxide synthase (ENOS); Polymorphisms

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA 2 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA DETERMINATION; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; OBESITY; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; TAIWAN;

ADULT; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR DISEASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS; TAIWAN;

EID: 33846511582     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.014     Document Type: Article

References (28)

1. Sacco RL, Boden-Albala B. Stroke risk factors: identification and modification. In: Fisher M, editor. Stroke therapy, 2nd ed. Oxford: Butterworth-Heinemann, 2001.
2. Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 2004;5:189-218.
3. Herrmann SM, Paul M. Studying genotype-phenotype relationships: cardiovascular disease as an example. J Mol Med 2002;80:282-9.
4. Website of Lien-Chiang County: www.matsu.gov.tw.
5. O'Malley JP, Maslen CL, Illingworth DR. Angiotensin-converting enzyme and cardiovascular disease risk. Curr Opin Lipidol 1999;10:407-15.
6. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, et al. Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin Sci 2000;98:251-8.
7. 2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000;101:2877-82.
8. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998;32:3-8.
9. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
10. Lee Y, Lin RS, Sung FC, Yang C, Chien K, Chen W, et al. Chin-Shan Community Cardiovascular Cohort in Taiwan - baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 2000;53:838-46.
11. Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol 2002;5:188-99.
12. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ. Comparative Risk Assessment Collaborating Group. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003;362:271-80.
13. Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 2002;62:977-93.
14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
15. del Ser T, Bornstein B, Barba R, Cemillan C. Relationship of angiotensin converting enzyme genotype with serum triglyceride concentration in stroke patients. Neurosci Lett 2001;316:21-4.
16. Prisco D, Fatini C, Battaglini B, Gensini F, Fedi S, Falai M, et al. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients. Int J Clin Lab Res 2000;30:179-85.
17. Byberg L, Siegbahn A, Berglund L, McKeigue P, Reneland R, Lithell H. Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. Arterioscler Thromb Vasc Biol 1998;18:258-64.
18. Radomski MW, Salas E. Nitric oxide y biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis 1995;118(Suppl):S69-80.
19. Dimmeler S, Zeiher AM. Nitric oxide - an endothelial cell survival factor. Cell Death Differ 1999;6:964-8.
20. McDonald DM, Alp NJ, Channon KM. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 2004;14:831-9.
21. Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG. Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298→Asp and T-786→C polymorphisms. Stroke 2004;35:1305-9.
22. Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Alfieri AB, Cubeddu LX. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005;19:233-40.
23. 2-adrenergic receptors. J Biol Chem 1999;274:16701-8.
24. 2 adrenergic receptor gene Arg16Gly polymorphism is associated with therapeutic efficacy of benazepril on essential hypertension in Chinese. Clin Exp Hypertens 2004;26:581-92.
25. Lang RE, Unger T, Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens 1987;5:255-71.
26. Rubattu S, Ridker P, Stampfer MJ, Volpe M, Hennekens CH, Lindpaintner K. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 1999;100:1722-6.
27. Lin YC, Chang YM, Yu JM, Yen JH, Chang JG, Hu CJ. Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 2005;180:305-9.
28. Hassan A, Ali N, Dong Y, Carter ND, Markus HS. Atrial natriuretic peptide gene G664A polymorphism and the risk of ischemic cerebrovascular disease. Neurology 2001;57:1726-8.